| 1996 | 4기 위암의 적절한 치료법은?
| Journal of the Korean Cancer Association(대한암학회지) |
| 2019 | A case of gastric cancer metastasis to the breast in a female with BRCA2 germline mutation and literature review | ACTA CHIRURGICA BELGICA |
| 2019 | A High Visceral-To-Subcutaneous Fat Ratio is an Independent Predictor of Surgical Site Infection after Gastrectomy
| JOURNAL OF CLINICAL MEDICINE |
| 2019 | A Lesion-Based Convolutional Neural Network Improves Endoscopic Detection and Depth Prediction of Early Gastric Cancer
| Journal of Clinical Medicine |
| 2016 | A Lymph Node Staging System for Gastric Cancer: A Hybrid Type Based on Topographic and Numeric Systems
| PLOS ONE |
| 2020 | A Multi-cohort Study of the Prognostic Significance of Microsatellite Instability or Mismatch Repair Status after Recurrence of Resectable Gastric Cancer
| CANCER RESEARCH AND TREATMENT |
| 2009 | A novel modification of double stapling technique in Billroth I anastomosis | JOURNAL OF SURGICAL ONCOLOGY |
| 2016 | A Novel Prediction Model of Prognosis After Gastrectomy for Gastric Carcinoma: Development and Validation Using Asian Databases. | ANNALS OF SURGERY |
| 2009 | A phase II feasibility study of weekly paclitaxel in heavily pretreated advanced gastric cancer patients with poor performance status | ONCOLOGY |
| 2010 | A phase II study of a combined biweekly irinotecan and monthly cisplatin treatment for metastatic or recurrent gastric cancer. | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS |
| 2006 | A Phase II Study of Infusional 5-Fluorouracil and Low-Dose Leucovorin with Docetaxel for Advanced Gastric Cancer | ONCOLOGY |
| 2008 | A phase II study of paclitaxel combined with infusional 5-fluorouracil and low-dose leucovorin for advanced gastric cancer. | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2007 | A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status
| BRITISH JOURNAL OF CANCER |
| 2004 | A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer
| ANNALS OF ONCOLOGY |
| 2007 | A phase II trial of weekly fractionated irinotecan and cisplatin for advanced gastric cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2013 | A Pilot Study for Preoperative Concurrent Chemoradiotherapy with S-1 and Cisplatin for Locally Advanced Gastric Cancer | HEPATO-GASTROENTEROLOGY |
| 2012 | A pilot study of S-1 plus cisplatin versus 5-fluorouracil plus cisplatin for postoperative chemotherapy in histological stage IIIB-IV (M0) gastric cancer | INVESTIGATIONAL NEW DRUGS |
| 2011 | A prognostic model to predict clinical outcome in gastric cancer patients with bone metastasis | ONCOLOGY |
| 2024 | A randomized controlled study to assess the effect of mosapride citrate on intestinal recovery following gastrectomy
| SCIENTIFIC REPORTS |
| 2017 | A randomized controlled trial of Roux-en-Y gastrojejunostomy vs. gastroduodenostomy with respect to the improvement of type 2 diabetes mellitus after distal gastrectomy in gastric cancer patients.
| PLOS ONE |
| 2011 | A randomized phase 2 study of docetaxel and S-1 versus docetaxel and cisplatin in advanced gastric cancer with an evaluation of SPARC expression for personalized therapy
| CANCER |
| 2019 | A therapeutic strategy for chemotherapy-resistant gastric cancer via destabilization of both β-catenin and ras
| CANCERS |
| 2017 | Additive endoscopic resection may be sufficient for patients with a positive lateral margin after endoscopic resection of early gastric cancer | GASTROINTESTINAL ENDOSCOPY |
| 2012 | Additive lymph node dissection may be necessary in minute submucosal cancer of the stomach after endoscopic resection | ANNALS OF SURGICAL ONCOLOGY |
| 2004 | Adeno-associated virus mediated endostatin gene therapy in combination with topoisomerase inhibitor effectively controls liver tumor in mouse model
| WORLD JOURNAL OF GASTROENTEROLOGY |
| 2001 | Adjuvant 5-fluorouracil plus doxorubicin in D2-3 resected gastric carcinoma: 15-year experience at a single institute. | CANCER |
| 2012 | Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial | LANCET |
| 2014 | Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. | LANCET ONCOLOGY |
| 2011 | Advanced detection of recent changing trends in gastric cancer survival: up-to-date comparison by period analysis.
| JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
| 2013 | Advanced gastric cancer: is chemotherapy needed after surgery? | EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY |
| 2007 | Advanced Gastric Carcinoma with Signet Ring Cell Histology | ONCOLOGY |
| 2006 | Adverse effect of splenectomy on recurrence in total gastrectomy cancer patients with perioperative transfusion | AMERICAN JOURNAL OF SURGERY |
| 2002 | Adverse effects of perioperative transfusion on patients with stage III and IV gastric cancer. | ANNALS OF SURGICAL ONCOLOGY |
| 1998 | Alpha-fetoprotein-producing gastric cancer | ONCOLOGY REPORTS |
| 2002 | Altered Expression of Lewis Antigen on Tissue and Erythrocytes in Gastric Cancer Patients
| YONSEI MEDICAL JOURNAL |
| 2020 | Altered systematic glucose utilization after gastrectomy: correlation with weight loss | SURGERY FOR OBESITY AND RELATED DISEASES |
| 2012 | AMPKα modulation in cancer progression: multilayer integrative analysis of the whole transcriptome in Asian gastric cancer.
| CANCER RESEARCH |
| 1998 | An unusual case of gastric carcinoma with synchronous non-Hodgkin's lymphoma
| YONSEI MEDICAL JOURNAL |
| 2010 | Analysis of demographic characteristics in 3242 young age gastric cancer patients in Korea
| WORLD JOURNAL OF GASTROENTEROLOGY |
| 2014 | Anatomic extent of metastatic lymph nodes: Still important for gastric cancer prognosis | ANNALS OF SURGICAL ONCOLOGY |
| 2014 | Angiogenic factor thymidine phosphorylase associates with angiogenesis and lymphangiogenesis in the intestinal-type gastric cancer | PATHOLOGY |
| 2008 | Angiogenic factor thymidine phosphorylase increases cancer cell invasion activity in patients with gastric adenocarcinoma.
| MOLECULAR CANCER RESEARCH |
| 2004 | Application of minimally invasive treatment for early gastric cancer | JOURNAL OF SURGICAL ONCOLOGY |
| 2016 | Are new criteria for mixed histology necessary for endoscopic resection in early gastric cancer? | PATHOLOGY RESEARCH AND PRACTICE |
| 2016 | Assessment of Adrenal Function and Health-Related Quality of Life in Advanced Gastric Cancer Patients Who Received First-Line Chemotherapy. | ONCOLOGY |
| 2010 | Assessment of open versus laparoscopy-assisted gastrectomy in lymph node-positive early gastric cancer: a retrospective cohort analysis | JOURNAL OF SURGICAL ONCOLOGY |
| 2015 | Association between Chemotherapy-Response Assays and Subsets of Tumor-Infiltrating Lymphocytes in Gastric Cancer: A Pilot Study
| JOURNAL OF GASTRIC CANCER |
| 2010 | Association of the ABCB1 3435C>T polymorphism and treatment outcomes in advanced gastric cancer patients treated with paclitaxel-based chemotherapy. | ONCOLOGY REPORTS |
| 2007 | ATP-Based Chemotherapy Response Assay in Patients with Unresectable Gastric Cancer | ONCOLOGY |
| 2002 | Biological phenotype determination with ex vivo model in gastric cancer for matrix-metalloproteinase inhibitor treatment. | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE |
| 1996 | Borrmann Type IV 위암의 특성과 예후인자 | JOURNAL OF THE KOREAN SURGICAL SOCIETY (대한외과학회지) |
| 2014 | Can we apply the same indication of endoscopic submucosal dissection for primary gastric cancer to remnant gastric cancer? | GASTRIC CANCER |
| 2008 | Changes in treatment outcomes of gastric cancer surgery over 45 years at a single institution.
| YONSEI MEDICAL JOURNAL |
| 2007 | Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: A 15-year follow-up study at a single korean institute | ANNALS OF SURGICAL ONCOLOGY |
| 2010 | Chemokine growth-regulated oncogene 1 as a putative biomarker for gastric cancer progression | CANCER SCIENCE |
| 2020 | Chimeric Antigen Receptor T Cell Therapy Targeting ICAM-1 in Gastric Cancer
| MOLECULAR THERAPY-ONCOLYTICS |
| 2010 | Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients | CANCER LETTERS |
| 2018 | Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype
| Nature Communications |
| 2012 | Clinical implication of an insufficient number of examined lymph nodes after curative resection for gastric cancer | CANCER |
| 2013 | Clinical implication of endoscopic gross appearance in early gastric cancer: revisited | SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES |
